The estimated Net Worth of Jon Patrick Hunt is at least $53.9 mil dollars as of 11 November 2021. Dr Hunt owns over 23,976 units of HeartBeam Inc stock worth over $53,946 and over the last 3 years he sold BEAT stock worth over $0.
Dr has made over 1 trades of the HeartBeam Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 23,976 units of BEAT stock worth $100,699 on 11 November 2021.
The largest trade he's ever made was exercising 23,976 units of HeartBeam Inc stock on 11 November 2021 worth over $100,699. On average, Dr trades about 11,988 units every 0 days since 2021. As of 11 November 2021 he still owns at least 23,976 units of HeartBeam Inc stock.
You can see the complete history of Dr Hunt stock trades at the bottom of the page.
Dr. Jon Hunt Ph.D. is the Exec. VP & Chief Bus. Officer at HeartBeam Inc.
Dr D is 65, he's been the Exec. VP & Chief Bus. Officer of HeartBeam Inc since . There are 8 older and 9 younger executives at HeartBeam Inc. The oldest executive at HeartBeam Inc is Robert Rubin, 74, who is the Independent Director.
Jon's mailing address filed with the SEC is 2118 WALSH AVE, SUITE 210, , SANTA CLARA, CA, 95050.
Over the last 11 years, insiders at HeartBeam Inc have traded over $23,124,978 worth of HeartBeam Inc stock and bought 31,500 units worth $221,145 . The most active insiders traders include Joseph H Capper, Heather C Getz y Willem Elfrink. On average, HeartBeam Inc executives and independent directors trade stock every 32 days with the average trade being worth of $55,046. The most recent stock trade was executed by Urioste George De on 6 September 2024, trading 1,674 units of BEAT stock currently worth $3,917.
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
HeartBeam Inc executives and other stock owners filed with the SEC include: